Revolution Medicines, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26

Expected move

±6.3%implied · report alone

179.24203.38

straddle ±10.4%

spot 191.31exp Nov 20ATM strike 190ATM straddle 23.30IV 64%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±7.9%▲+0.26%×0.03

quarterimplied−10%0+10%realized×

Q2 FY26±7.9%▲+0.26%×0.03

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull2 of 4

+23.58%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

700managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

7 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

42managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

RVMD report session

No linked exposure.

Oct 21impliedImplied move: ±11.2% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.